Exelixis, Inc.
EXEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000939767
In the last 90 days, Exelixis, Inc. insiders filed 0 open-market purchases and 1 sale; 760 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Exelixis, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 376
- +21 vs. Q1 2022
- Shares held
- 276.8M
- +8.01M (+3.0%) vs. Q1 2022
- Total value
- $5.78B
- −$307.2M (−5.0%) vs. Q1 2022
- New holders
- 55
- 151 more added
- Sold out
- 34
- 111 more reduced
8 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EXEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 760 | $14.1B |
| Q1 2026 | 701 | $11.1B |
| Q4 2025 | 685 | $11.4B |
| Q3 2025 | 622 | $10.4B |
| Q2 2025 | 635 | $11.2B |
| Q1 2025 | 559 | $9.35B |
| Q4 2024 | 519 | $8.33B |
| Q3 2024 | 454 | $6.45B |
| Q2 2024 | 416 | $5.47B |
| Q1 2024 | 422 | $6.02B |
| Q4 2023 | 427 | $6.21B |
| Q3 2023 | 400 | $5.78B |
| Q2 2023 | 380 | $5.22B |
| Q1 2023 | 366 | $5.45B |
| Q4 2022 | 388 | $4.49B |
| Q3 2022 | 402 | $4.33B |
| Q2 2022 | 376 | $5.78B |
| Q1 2022 | 363 | $6.11B |
| Q4 2021 | 329 | $4.89B |
| Q3 2021 | 341 | $5.63B |
| Q2 2021 | 345 | $4.88B |
| Q1 2021 | 348 | $5.92B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Exelixis, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1,764−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −464−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| CFS Investment Advisory Services, LLC | 0 | $0 | 0.00% | −28,338−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Lenox Wealth Advisors, LLC | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |